These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Newborn screening for cystic fibrosis: techniques and strategies. Wilcken B J Inherit Metab Dis; 2007 Aug; 30(4):537-43. PubMed ID: 17505915 [TBL] [Abstract][Full Text] [Related]
83. The incidence of different cystic fibrosis mutations in the Scottish population: effects on prenatal diagnosis and genetic counselling. Shrimpton AE; McIntosh I; Brock DJ J Med Genet; 1991 May; 28(5):317-21. PubMed ID: 1713973 [TBL] [Abstract][Full Text] [Related]
84. UK clinicians' knowledge of and attitudes to the prenatal diagnosis of single gene disorders. Firth HV; Lindenbaum RH J Med Genet; 1992 Jan; 29(1):20-3. PubMed ID: 1532425 [TBL] [Abstract][Full Text] [Related]
85. The Scottish molecular genetics consortium--15 years on. Kelly KF Health Bull (Edinb); 2002 Jan; 60(1):83-90. PubMed ID: 12664773 [TBL] [Abstract][Full Text] [Related]
86. Molecular genetics in clinical practice: evolution of a DNA diagnostic service. Meredith AL; Upadhyaya M; Harper PS BMJ; 1988 Oct; 297(6652):843-6. PubMed ID: 2972330 [TBL] [Abstract][Full Text] [Related]
88. Duchenne and Becker muscular dystrophies: genetics, prenatal diagnosis, and future prospects. Bieber FR; Hoffman EP Clin Perinatol; 1990 Dec; 17(4):845-65. PubMed ID: 2286031 [TBL] [Abstract][Full Text] [Related]
89. Screening for cystic fibrosis. Heeley AF J Pediatr; 1983 Nov; 103(5):836. PubMed ID: 6631621 [No Abstract] [Full Text] [Related]
90. Guthrie cards for detection of point mutations in phenylketonuria. Lyonnet S; Caillaud C; Rey F; Berthelon M; Frezal J; Rey J; Munnich A Lancet; 1988 Aug; 2(8609):507. PubMed ID: 2900424 [No Abstract] [Full Text] [Related]
91. Same-day, first-trimester antenatal diagnosis for cystic fibrosis by gene amplification. Williams C; Williamson R; Coutelle C; Loeffler F; Smith J; Ivinson A Lancet; 1988 Jul; 2(8602):102-3. PubMed ID: 2898671 [No Abstract] [Full Text] [Related]
92. Prenatal diagnosis of alpha-1-antitrypsin deficiency using polymerase chain reaction. Abbott CM; McMahon CJ; Whitehouse DB; Povey S Lancet; 1988 Apr; 1(8588):763-4. PubMed ID: 2895285 [No Abstract] [Full Text] [Related]
93. Predictive testing for Huntington's disease with linked DNA markers. Brock DJ; Mennie M; Curtis A; Millan FA; Barron L; Raeburn JA; Dinwoodie D; Holloway S; Crosbie A; Wright A Lancet; 1989 Aug; 2(8661):463-6. PubMed ID: 2570183 [TBL] [Abstract][Full Text] [Related]
94. Prenatal exclusion testing for Huntington disease using the polymerase chain reaction. McIntosh I; Curtis A; Millan FA; Brock DJ Am J Med Genet; 1989 Feb; 32(2):274-6. PubMed ID: 2564738 [TBL] [Abstract][Full Text] [Related]
95. Prenatal exclusion testing for Huntington's disease: a problem of too much information. Millan FA; Curtis A; Mennie M; Holloway S; Boxer M; Faed MJ; Crawford JW; Liston WA; Brock DJ J Med Genet; 1989 Feb; 26(2):83-5. PubMed ID: 2563777 [TBL] [Abstract][Full Text] [Related]
96. Molecular genetics in the National Health Service in Britain. Harris R; Elles R; Craufurd D; Dodge A; Ivinson A; Hodgkinson K; Mountford R; Schwartz M; Strachan T; Read A J Med Genet; 1989 Apr; 26(4):219-25. PubMed ID: 2523972 [TBL] [Abstract][Full Text] [Related]
97. A consortium approach to molecular genetic services. Scottish Molecular Genetics Consortium. Brock DJ J Med Genet; 1990 Jan; 27(1):8-13. PubMed ID: 2308159 [TBL] [Abstract][Full Text] [Related]